Syros Pharmaceuticals
A company focused on mapping and controlling the genes to treat diseases
13
Funding Rounds
$670.2m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** E. Br***** | - | - | |
| Na******* Gr** | - | - | |
| Al******* Ri*** (e************ | - | - | linkedin twitter facebook |
| Ri***** Yo*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** Wi*** | - | - | - |
| Ri***** A. Yo*** | - | - | - |
| Sr****** Ak****** | - | - | - |
| De***** Du***** | - | - | |
| Ma**** H. Fa***** | - | - | - |
| Na*** Si****** | - | - | |
| Ma** Al*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Syros Pharmaceuticals has raised a total of $159.84m in funding over 13 rounds.
Key Insights:
- Syros Pharmaceuticals Funding Round, September 2022: $129.84m
- Syros Pharmaceuticals Series A round: $30m
- Syros Pharmaceuticals, Inc. funding round, December 2020: $121.61m
- Syros Pharmaceuticals Venture round, January 2021: $75.6m
- Syros Pharmaceuticals Venture round, December 2020: $90.5m
- Syros Pharmaceuticals Venture round, February 2020: $60m
- Syros Pharmaceuticals Venture round, February 2018: $11.4m
- Syros Pharmaceuticals Venture round, April 2017: $35m
- Syros Pharmaceuticals Series C round, January 2016: $40m
- Syros Pharmaceuticals Series B round, October 2014: $53m
- Syros Pharmaceuticals, Inc. funding round, January 2018: $10m
- Syros Pharmaceuticals, Inc. funding round, April 2013: $12m
- LS22, Inc. funding round, August 2012: $1.25m
Syros Pharmaceuticals Funding Round, September 2022
$129.84m
Syros Pharmaceuticals Series A round
$30m
Syros Pharmaceuticals, Inc. funding round, December 2020
$121.61m
Syros Pharmaceuticals Venture round, January 2021
$75.6m
Syros Pharmaceuticals Venture round, December 2020
$90.5m
Syros Pharmaceuticals Venture round, February 2020
$60m
Syros Pharmaceuticals Venture round, February 2018
$11.4m
Syros Pharmaceuticals Venture round, April 2017
$35m
Syros Pharmaceuticals Series C round, January 2016
$40m
Syros Pharmaceuticals Series B round, October 2014
$53m
Syros Pharmaceuticals, Inc. funding round, January 2018
$10m
Syros Pharmaceuticals, Inc. funding round, April 2013
$12m
LS22, Inc. funding round, August 2012
$1.25m
Industries
Syros Pharmaceuticals is active in the following industries:
- Engineering
- Genetics
- Biology
- Biotechnology
- Technology
- Enzyme kinetics
- Chemistry
- Biomedical engineering
- Life science
